Geistlich Fibro Gide

Geistlich Fibro-Gide®
The first volume-stable collagen matrix designed for gaining soft-tissue thickness.4,6

HANSAmed Geistlich Fibro Gide

Introducing Geistlich
Fibro-Gide®

Geistlich Fibro-Gide® is a volume-stable collagen matrix, specifically designed for soft-tissue regeneration.

As the alternative connective tissue graft, Geistlich Fibro-Gide® is ideally suited for soft-tissue augmentation around natural teeth and implants, as a submerged scaffold where an increase in soft-tissue thickness is clinically desired. Additionally, Geistlich Fibro-Gide® is indicated for alveolar ridge reconstruction for prosthetic treatment and recession defects for root coverage.

Before You Begin…

We encourage you review the resources available, to enhance your understanding, surgical comfort and handling of Geistlich Fibro-Gide®.

Geistlich Fibro-Gide®

Educational Webinar

All you need to succeed

 

Made of Collagen

A porcine, porous, resorbable and volume-stable collagen matrix.1

Volume Stability

The reconstituted collagen undergoes smart cross-linking for volume stability of the matrix.1

Soft-Tissue Integration

In vivo animal studies have shown ~ 97% remodeling of the collagen matrix after approximately 26 weeks.4

Soft-Tissue Formation

The porous network of the matrix supports angiogenesis, the formation of new connective tissue and stability of the collagen network in submerged healing situations.2,3

Surgical Videos

Case 1: Soft-tissue augmentation around a dental implant

Case 2: Soft-tissue augmentation around a dental implant

Root Coverage of a single recession defect

3D Animated Videos

Soft-tissue augmentation around a dental implant 3D Animated Video

Root coverage of a single recession defect 3D Animated Video

Handling
at a Glance

Flap Design

Use your preferred flap design. A generous release of the flap is the key to successful healing by complete coverage of the matrix (submerged healing).

Contents are based on preclinical and clinical evidence gained in Europe during the Geistlich Fibro-Gide® pre-launch phase.

Precise Trimming

Using a scalpel will help in achieving smooth edges and bevels for improved wound adaptation and precise fit of the matrix.

Contents are based on preclinical and clinical evidence gained in Europe during the Geistlich Fibro-Gide® pre-launch phase.

Thickness

The thickness of Geistlich Fibro-Gide® close to the wound margins should be reduced to avoid dehiscence during the healing phase.

Contents are based on preclinical and clinical evidence gained in Europe during the Geistlich Fibro-Gide® pre-launch phase.

Adhesion

When hydrated the matrix will adhere rapidly. Suturing the device to the underlying soft-tissue is not always necessary.

Contents are based on preclinical and clinical evidence gained in Europe during the Geistlich Fibro-Gide® pre-launch phase.

Wound Closure

Tension-free closure of the flap is key for complication-free healing and may avoid any dehiscences.

Contents are based on preclinical and clinical evidence gained in Europe during the Geistlich Fibro-Gide® pre-launch phase.

Handling

As with any new product, initially, you will experience some differences in the handling properties and performance of the matrix.

Contents are based on preclinical and clinical evidence gained in Europe during the Geistlich Fibro-Gide® pre-launch phase.

Healing

Clinical experience shows a low incidence of wound healing complications.3,5

Contents are based on preclinical and clinical evidence gained in Europe during the Geistlich Fibro-Gide® pre-launch phase.

Fit to Size

The matrix can be cut and trimmed in a dry or wet state with scissors and/or a scalpel and can be adjusted in size or thickness to achieve the desired augmentation.

Contents are based on preclinical and clinical evidence gained in Europe during the Geistlich Fibro-Gide® pre-launch phase.

Volume Changes

Swelling of the device upon wetting must be taken into account when determining final dimensions, as the matrix will gain approximately 25% in volume.

Contents are based on preclinical and clinical evidence gained in Europe during the Geistlich Fibro-Gide® pre-launch phase.

Application

Geistlich Fibro-Gide® can be applied in either a dry or wet state upon individual preference. Pre-wetting can be done with the patient’s own blood, you may also dampen with sterile saline solution, but do not fully hydrate the matrix.

Contents are based on preclinical and clinical evidence gained in Europe during the Geistlich Fibro-Gide® pre-launch phase.

In Situ Adaptation

Prior to wound closure, ensure a tension-free flap and complete coverage of the matrix.

Contents are based on preclinical and clinical evidence gained in Europe during the Geistlich Fibro-Gide® pre-launch phase.

Downloads

Product
Brochure

Download

Product
Sell Sheet

Download

Technical
Guidelines

Download

Clinical Article
Infographic

Download

Geistlich Fibro-Gide®

The Alternative
Soft-Tissue Graft

CAUTION: Federal law restricts these devices to sale by or on the order of a dentist or physician.

Indications:
Geistlich Fibro-Gide® is indicated for soft-tissue augmentation:

  • Localized gingival augmentation to increase keratinized tissue (KT) around teeth and implants
  • Alveolar ridge reconstruction for prosthetic treatment
  • Recession defect for root coverage

Warnings:
As Geistlich Fibro-Gide® is a collagen product, allergic reactions may not be totally excluded. Possible complications which may occur with any surgery include swelling at the surgical site, flap sloughing, bleeding, dehiscence, hematoma, increased sensitivity and pain, redness and local inflammation.

For more information on contraindications, precautions, and directions for use, please refer to the Geistlich Biomaterials Instructions for Use at: www.geistlich-na.com/ifu.

  1. Instructions for Use. Geistlich Fibro-Gide®.
    Geistlich Pharma AG, Wolhusen, Switzerland.
  2. Thoma DS. et al. J Clin Periodontol. 2016 Oct; 43(10): 874–85.
  3. Thoma DS. et al. Clin Oral Implants Res. 2015 Mar; 26(3): 263–70.
  4. Data on file. Geistlich Pharma AG, Wolhusen, Switzerland.
  5. Zeltner M. et al. J Clin Periodontol. 2017 Apr; 44(4): 446–453.
  6. European Patent Specification – EP 3 055 000 B1.

Geistlich Pharma North America, Inc.
202 Carnegie Center
Princeton, NJ 08540
Customer Care Toll-free: 855-799-5500
[email protected]
www.geistlich-na.com

GB-1096-18E ©2018 Geistlich Biomaterials